UniProt ID | TBCB_HUMAN | |
---|---|---|
UniProt AC | Q99426 | |
Protein Name | Tubulin-folding cofactor B | |
Gene Name | TBCB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 244 | |
Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton . Colocalizes with microtubules. In differentiated neurons, located in the cytoplasm. In differentiating neurons, accumulates at the growth cone. | |
Protein Description | Binds to alpha-tubulin folding intermediates after their interaction with cytosolic chaperonin in the pathway leading from newly synthesized tubulin to properly folded heterodimer. [PubMed: 9265649 Involved in regulation of tubulin heterodimer dissociation. May function as a negative regulator of axonal growth (By similarity] | |
Protein Sequence | MEVTGVSAPTVTVFISSSLNTFRSEKRYSRSLTIAEFKCKLELLVGSPASCMELELYGVDDKFYSKLDQEDALLGSYPVDDGCRIHVIDHSGARLGEYEDVSRVEKYTISQEAYDQRQDTVRSFLKRSKLGRYNEEERAQQEAEAAQRLAEEKAQASSIPVGSRCEVRAAGQSPRRGTVMYVGLTDFKPGYWIGVRYDEPLGKNDGSVNGKRYFECQAKYGAFVKPAVVTVGDFPEEDYGLDEI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEVTGVSA -------CCCCCCCC | 9.37 | 22223895 | |
15 | Ubiquitination | APTVTVFISSSLNTF CCEEEEEEECCCCHH | 3.20 | 32015554 | |
29 | Phosphorylation | FRSEKRYSRSLTIAE HCCCCCCCCCEEHHE | 21.30 | 29514088 | |
31 | Phosphorylation | SEKRYSRSLTIAEFK CCCCCCCCEEHHEEE | 24.75 | 30266825 | |
33 | Phosphorylation | KRYSRSLTIAEFKCK CCCCCCEEHHEEEEE | 21.27 | 30266825 | |
38 | Ubiquitination | SLTIAEFKCKLELLV CEEHHEEEEEEEEEC | 23.20 | 33845483 | |
55 | Ubiquitination | PASCMELELYGVDDK CCCCEEEEEECCCHH | 27.00 | 23000965 | |
62 | Ubiquitination | ELYGVDDKFYSKLDQ EEECCCHHHHHCCCH | 41.56 | 32015554 | |
65 | Phosphorylation | GVDDKFYSKLDQEDA CCCHHHHHCCCHHHC | 29.85 | 15831477 | |
66 | Ubiquitination | VDDKFYSKLDQEDAL CCHHHHHCCCHHHCC | 44.71 | 32015554 | |
91 | Phosphorylation | RIHVIDHSGARLGEY EEEEECCCCCCCCCC | 30.33 | 20068231 | |
98 | Phosphorylation | SGARLGEYEDVSRVE CCCCCCCCCCHHHEE | 18.68 | 21945579 | |
102 | Phosphorylation | LGEYEDVSRVEKYTI CCCCCCHHHEEEEEC | 42.82 | 21945579 | |
102 | Ubiquitination | LGEYEDVSRVEKYTI CCCCCCHHHEEEEEC | 42.82 | 32142685 | |
106 | Ubiquitination | EDVSRVEKYTISQEA CCHHHEEEEECCHHH | 44.85 | 21890473 | |
106 | 2-Hydroxyisobutyrylation | EDVSRVEKYTISQEA CCHHHEEEEECCHHH | 44.85 | - | |
106 | Ubiquitination | EDVSRVEKYTISQEA CCHHHEEEEECCHHH | 44.85 | 23000965 | |
107 | Phosphorylation | DVSRVEKYTISQEAY CHHHEEEEECCHHHH | 8.87 | 28796482 | |
108 | Phosphorylation | VSRVEKYTISQEAYD HHHEEEEECCHHHHH | 25.81 | 28152594 | |
110 | Phosphorylation | RVEKYTISQEAYDQR HEEEEECCHHHHHHH | 17.73 | 17525332 | |
114 | Phosphorylation | YTISQEAYDQRQDTV EECCHHHHHHHHHHH | 16.32 | 28674151 | |
120 | Phosphorylation | AYDQRQDTVRSFLKR HHHHHHHHHHHHHHH | 14.96 | 23312004 | |
123 | Phosphorylation | QRQDTVRSFLKRSKL HHHHHHHHHHHHHHH | 30.51 | 24719451 | |
128 | Phosphorylation | VRSFLKRSKLGRYNE HHHHHHHHHHCCCCH | 30.55 | 15831477 | |
133 | Phosphorylation | KRSKLGRYNEEERAQ HHHHHCCCCHHHHHH | 25.73 | - | |
137 | Ubiquitination | LGRYNEEERAQQEAE HCCCCHHHHHHHHHH | 47.33 | 32015554 | |
152 | Neddylation | AAQRLAEEKAQASSI HHHHHHHHHHHHHCC | 48.35 | 32015554 | |
152 | Ubiquitination | AAQRLAEEKAQASSI HHHHHHHHHHHHHCC | 48.35 | 22817900 | |
153 | Acetylation | AQRLAEEKAQASSIP HHHHHHHHHHHHCCC | 36.99 | 23954790 | |
153 | 2-Hydroxyisobutyrylation | AQRLAEEKAQASSIP HHHHHHHHHHHHCCC | 36.99 | - | |
153 | Malonylation | AQRLAEEKAQASSIP HHHHHHHHHHHHCCC | 36.99 | 26320211 | |
153 | Ubiquitination | AQRLAEEKAQASSIP HHHHHHHHHHHHCCC | 36.99 | 21906983 | |
168 | Ubiquitination | VGSRCEVRAAGQSPR CCCCCEEEECCCCCC | 9.09 | - | |
168 | Acetylation | VGSRCEVRAAGQSPR CCCCCEEEECCCCCC | 9.09 | 19608861 | |
168 | Ubiquitination | VGSRCEVRAAGQSPR CCCCCEEEECCCCCC | 9.09 | 23000965 | |
173 | Phosphorylation | EVRAAGQSPRRGTVM EEEECCCCCCCCEEE | 21.32 | 20068231 | |
174 | Ubiquitination | VRAAGQSPRRGTVMY EEECCCCCCCCEEEE | 23.31 | 23000965 | |
178 | Phosphorylation | GQSPRRGTVMYVGLT CCCCCCCEEEEEECC | 10.57 | 26074081 | |
181 | Phosphorylation | PRRGTVMYVGLTDFK CCCCEEEEEECCCCC | 6.24 | 26074081 | |
185 | Phosphorylation | TVMYVGLTDFKPGYW EEEEEECCCCCCCEE | 33.20 | 26074081 | |
188 | Ubiquitination | YVGLTDFKPGYWIGV EEECCCCCCCEEEEE | 40.10 | 32015554 | |
203 | Ubiquitination | RYDEPLGKNDGSVNG EECCCCCCCCCCCCC | 60.59 | 21906983 | |
203 | Malonylation | RYDEPLGKNDGSVNG EECCCCCCCCCCCCC | 60.59 | 26320211 | |
203 | Neddylation | RYDEPLGKNDGSVNG EECCCCCCCCCCCCC | 60.59 | 32015554 | |
211 | Ubiquitination | NDGSVNGKRYFECQA CCCCCCCEEEEEEEH | 38.43 | - | |
219 | Ubiquitination | RYFECQAKYGAFVKP EEEEEEHCCCCEECC | 20.52 | 23000965 | |
219 | Acetylation | RYFECQAKYGAFVKP EEEEEEHCCCCEECC | 20.52 | 19608861 | |
219 | Ubiquitination | RYFECQAKYGAFVKP EEEEEEHCCCCEECC | 20.52 | 21890473 | |
220 | Phosphorylation | YFECQAKYGAFVKPA EEEEEHCCCCEECCE | 19.39 | 26356563 | |
225 | Ubiquitination | AKYGAFVKPAVVTVG HCCCCEECCEEEEEC | 22.32 | 23000965 | |
230 | Phosphorylation | FVKPAVVTVGDFPEE EECCEEEEECCCCHH | 16.51 | 26356563 | |
239 | Phosphorylation | GDFPEEDYGLDEI-- CCCCHHHCCCCCC-- | 23.91 | 28674151 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TBCB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TBCB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GAN_HUMAN | GAN | physical | 16303566 | |
TXND5_HUMAN | TXNDC5 | physical | 22939629 | |
TCTP_HUMAN | TPT1 | physical | 22939629 | |
AL7A1_HUMAN | ALDH7A1 | physical | 22863883 | |
ASNS_HUMAN | ASNS | physical | 22863883 | |
CPNS1_HUMAN | CAPNS1 | physical | 22863883 | |
KCRB_HUMAN | CKB | physical | 22863883 | |
ISOC1_HUMAN | ISOC1 | physical | 22863883 | |
MARE1_HUMAN | MAPRE1 | physical | 22863883 | |
PDIA4_HUMAN | PDIA4 | physical | 22863883 | |
PP1A_HUMAN | PPP1CA | physical | 22863883 | |
PLPHP_HUMAN | PROSC | physical | 22863883 | |
RISC_HUMAN | SCPEP1 | physical | 22863883 | |
RUXF_HUMAN | SNRPF | physical | 22863883 | |
STK24_HUMAN | STK24 | physical | 22863883 | |
UBFD1_HUMAN | UBFD1 | physical | 22863883 | |
VINC_HUMAN | VCL | physical | 22863883 | |
1433E_HUMAN | YWHAE | physical | 22863883 | |
1433F_HUMAN | YWHAH | physical | 22863883 | |
ANXA6_HUMAN | ANXA6 | physical | 26344197 | |
D2HDH_HUMAN | D2HGDH | physical | 26344197 | |
HXK2_HUMAN | HK2 | physical | 26344197 | |
LGSN_HUMAN | LGSN | physical | 26344197 | |
PLBL2_HUMAN | PLBD2 | physical | 26344197 | |
PP14B_HUMAN | PPP1R14B | physical | 26344197 | |
XPP1_HUMAN | XPNPEP1 | physical | 26344197 | |
TBA4A_HUMAN | TUBA4A | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-219, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110, AND MASSSPECTROMETRY. | |
"p21-activated kinase 1 regulates microtubule dynamics byphosphorylating tubulin cofactor B."; Vadlamudi R.K., Barnes C.J., Rayala S., Li F., Balasenthil S.,Marcus S., Goodson H.V., Sahin A.A., Kumar R.; Mol. Cell. Biol. 25:3726-3736(2005). Cited for: SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-65 AND SER-128, ANDMUTAGENESIS OF SER-65 AND SER-128. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-98, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-98 AND TYR-114, AND MASSSPECTROMETRY. |